Computational pipeline predicting cell death suppressors as targets for cancer therapy

Area of Science:

• Computational biology
• Precision medicine
• Cancer research

Background:

• Identifying novel therapeutic targets is crucial for advancing precision medicine in oncology.
• Existing methods for target identification often lack integration of transcriptomic and drug response data.

Purpose of the Study:

• To develop and validate a computational pipeline for predicting cell-death suppressors as potential cancer therapeutic targets.
• To integrate transcriptomic similarity and cancer cell vulnerability data for robust target prediction.

Main Methods:

• Developed a two-module computational pipeline: transcriptomic similarity and gene expression-vulnerability correlation.
• Integrated modules into a single metric for predicting cell-death suppressors.
• Applied the pipeline to ferroptosis inducers in triple-negative breast cancer as a proof-of-concept.

Main Results:

• The pipeline reliably predicted candidate genes that act as ferroptosis suppressors.
• Predictions were validated using computational analyses and cellular assays.
• Demonstrated the pipeline's efficacy in identifying therapeutic targets for triple-negative breast cancer.

Conclusions:

• The developed computational pipeline offers a novel approach for identifying therapeutic targets in cancer.
• This method can be extended to discover repressors of various cell-death pathways for diverse cancer types.
• The pipeline supports the advancement of precision medicine through data integration and predictive modeling.